뉴로크린 바이오사이언시스 (NBIX)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Neurocrine Biosciences Inc (NBIX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	17.74% 959.00	814.50	805.50	794.90	687.50
Selling, General, and Administrative	38.05% 439.70	318.50	-	-	-
Costs And Expenses	30.01% 807.50	621.10	594.60	555.90	541.90
Operating Income/Loss	21.66% 151.50	193.40	210.90	239.00	145.60
Nonoperating Income/Loss	79.96% 10.70	53.40	28.50	52.80	13.90
Income/Loss From Continuing Operations Before Tax	34.28% 162.20	246.80	239.40	291.80	159.50
Income Tax Expense/Benefit	63.60% 17.80	48.90	85.70	82.30	52.00
Net Income/Loss	27.03% 144.40	197.90	153.70	209.50	107.50
Basic Average Shares	0.50% 101.00	100.50	0.20	99.40	99.00
Diluted Average Shares	0.77% 104.20	103.40	0.50	102.50	101.00
Basic Earnings Per Share	27.41% 1.43	1.97	1.54	2.11	1.09
Diluted Earnings Per Share	27.23% 1.39	1.91	1.48	2.04	1.06